|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
49 a.a.
|
 |
|
|
|
|
|
|
|
259 a.a.
|
 |
|
|
|
|
|
|
|
103 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Complex (serine protease/inhibitor)
|
 |
|
Title:
|
 |
Crystal structure of insect derived double domain kazal inhibitor rhodniin in complex with thrombin
|
|
Structure:
|
 |
Thrombin. Chain: l, j. Thrombin. Chain: h, k. Rhodniin. Chain: r, s. Engineered: yes
|
|
Source:
|
 |
Bos taurus. Cattle. Organism_taxid: 9913. Organ: plasma. Rhodnius prolixus. Organism_taxid: 13249. Gene: prpti. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.189
|
R-free:
|
0.263
|
|
|
Authors:
|
 |
A.Van De Locht,D.Lamba,W.Bode
|
|
Key ref:
|
 |
A.van de Locht
et al.
(1995).
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
Embo J,
14,
5149-5157.
PubMed id:
|
 |
|
Date:
|
 |
|
03-Mar-95
|
Release date:
|
14-Oct-96
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00735
(THRB_BOVIN) -
Prothrombin from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
625 a.a.
49 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H, J, K:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Embo J
14:5149-5157
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
|
|
A.van de Locht,
D.Lamba,
M.Bauer,
R.Huber,
T.Friedrich,
B.Kröger,
W.Höffken,
W.Bode.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Rhodniin is a highly specific inhibitor of thrombin isolated from the assassin
bug Rhodnius prolixus. The 2.6 Angstrum crystal structure of the non-covalent
complex between recombinant rhodniin and bovine alpha-thrombin reveals that the
two Kazal-type domains of rhodniin bind to different sites of thrombin. The
amino-terminal domain binds in a substrate-like manner to the narrow active-site
cleft of thrombin; the imidazole group of the P1 His residue extends into the S1
pocket to form favourable hydrogen/ionic bonds with Asp189 at its bottom, and
additionally with Glu192 at its entrance. The carboxy-terminal domain, whose
distorted reactive-site loop cannot adopt the canonical conformation, docks to
the fibrinogen recognition exosite via extensive electrostatic interactions. The
rather acidic polypeptide linking the two domains is displaced from the thrombin
surface, with none of its residues involved in direct salt bridges with
thrombin. The tight (Ki = 2 x 10(-13) M) binding of rhodniin to thrombin is the
result of the sum of steric and charge complementarity of the amino-terminal
domain towards the active-site cleft, and of the electrostatic interactions
between the carboxy-terminal domain and the exosite.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Calvo,
F.Tokumasu,
D.M.Mizurini,
P.McPhie,
D.L.Narum,
J.M.Ribeiro,
R.Q.Monteiro,
and
I.M.Francischetti
(2010).
Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo.
|
| |
FEBS J,
277,
413-427.
|
 |
|
|
|
|
 |
G.S.Min,
I.N.Sarkar,
and
M.E.Siddall
(2010).
Salivary transcriptome of the North American medicinal leech, Macrobdella decora.
|
| |
J Parasitol,
96,
1211-1221.
|
 |
|
|
|
|
 |
A.A.McFarlane,
and
J.Stetefeld
(2009).
An interdomain disulfide bridge links the NtA and first FS domain in agrin.
|
| |
Protein Sci,
18,
2421-2428.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Y.Koh,
and
R.M.Kini
(2008).
Anticoagulants from hematophagous animals.
|
| |
Expert Rev Hematol,
1,
135-139.
|
 |
|
|
|
|
 |
S.Macedo-Ribeiro,
C.Almeida,
B.M.Calisto,
T.Friedrich,
R.Mentele,
J.Stürzebecher,
P.Fuentes-Prior,
and
P.J.Pereira
(2008).
Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick.
|
| |
PLoS ONE,
3,
e1624.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.C.Assumpção,
I.M.Francischetti,
J.F.Andersen,
A.Schwarz,
J.M.Santana,
and
J.M.Ribeiro
(2008).
An insight into the sialome of the blood-sucking bug Triatoma infestans, a vector of Chagas' disease.
|
| |
Insect Biochem Mol Biol,
38,
213-232.
|
 |
|
|
|
|
 |
C.Y.Koh,
M.Kazimirova,
A.Trimnell,
P.Takac,
M.Labuda,
P.A.Nuttall,
and
R.M.Kini
(2007).
Variegin, a novel fast and tight binding thrombin inhibitor from the tropical bont tick.
|
| |
J Biol Chem,
282,
29101-29113.
|
 |
|
|
|
|
 |
A.Tartaglia-Polcini,
C.Bonnart,
A.Micheloni,
F.Cianfarani,
A.Andrè,
G.Zambruno,
A.Hovnanian,
and
M.D'Alessio
(2006).
SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.
|
| |
J Invest Dermatol,
126,
315-324.
|
 |
|
|
|
|
 |
B.Jarasrassamee,
P.Supungul,
S.Panyim,
S.Klinbunga,
V.Rimphanichayakit,
and
A.Tassanakajon
(2005).
Recombinant expression and characterization of five-domain Kazal-type serine proteinase inhibitor of black tiger shrimp (Penaeus monodon).
|
| |
Mar Biotechnol (NY),
7,
46-52.
|
 |
|
|
|
|
 |
W.Bode
(2005).
The structure of thrombin, a chameleon-like proteinase.
|
| |
J Thromb Haemost,
3,
2379-2388.
|
 |
|
|
|
|
 |
I.T.Campos,
B.G.Guimarães,
F.J.Medrano,
A.S.Tanaka,
and
J.A.Barbosa
(2004).
Crystallization, data collection and phasing of infestin 4, a factor XIIa inhibitor.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
2051-2053.
|
 |
|
|
|
|
 |
S.Liu,
C.Zhang,
H.Zhou,
and
Y.Zhou
(2004).
A physical reference state unifies the structure-derived potential of mean force for protein folding and binding.
|
| |
Proteins,
56,
93.
|
 |
|
|
|
|
 |
C.A.Innis,
and
M.Hyvönen
(2003).
Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding.
|
| |
J Biol Chem,
278,
39969-39977.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.A.Huntington,
and
T.P.Baglin
(2003).
Targeting thrombin--rational drug design from natural mechanisms.
|
| |
Trends Pharmacol Sci,
24,
589-595.
|
 |
|
|
|
|
 |
H.Hemmi,
T.Yoshida,
T.Kumazaki,
N.Nemoto,
J.Hasegawa,
F.Nishioka,
Y.Kyogoku,
H.Yokosawa,
and
Y.Kobayashi
(2002).
Solution structure of ascidian trypsin inhibitor determined by nuclear magnetic resonance spectroscopy.
|
| |
Biochemistry,
41,
10657-10664.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.T.Morris,
A.Coppin,
S.Tomavo,
and
V.B.Carruthers
(2002).
Functional analysis of Toxoplasma gondii protease inhibitor 1.
|
| |
J Biol Chem,
277,
45259-45266.
|
 |
|
|
|
|
 |
T.Myles,
B.F.Le Bonniec,
and
S.R.Stone
(2001).
The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
|
| |
Eur J Biochem,
268,
70-77.
|
 |
|
|
|
|
 |
X.Nirmala,
D.Kodrík,
M.Zurovec,
and
F.Sehnal
(2001).
Insect silk contains both a Kunitz-type and a unique Kazal-type proteinase inhibitor.
|
| |
Eur J Biochem,
268,
2064-2073.
|
 |
|
|
|
|
 |
J.L.Richardson,
B.Kröger,
W.Hoeffken,
J.E.Sadler,
P.Pereira,
R.Huber,
W.Bode,
and
P.Fuentes-Prior
(2000).
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
|
| |
EMBO J,
19,
5650-5660.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.S.Cupp,
D.Zhang,
and
E.W.Cupp
(2000).
Horn fly (Diptera: Muscidae) saliva targets thrombin action in hemostasis.
|
| |
J Med Entomol,
37,
416-421.
|
 |
|
|
|
|
 |
W.R.Montfort,
A.Weichsel,
and
J.F.Andersen
(2000).
Nitrophorins and related antihemostatic lipocalins from Rhodnius prolixus and other blood-sucking arthropods.
|
| |
Biochim Biophys Acta,
1482,
110-118.
|
 |
|
|
|
|
 |
A.Lombardi,
G.De Simone,
S.Galdiero,
N.Staiano,
F.Nastri,
and
V.Pavone
(1999).
From natural to synthetic multisite thrombin inhibitors.
|
| |
Biopolymers,
51,
19-39.
|
 |
|
|
|
|
 |
H.Czapinska,
and
J.Otlewski
(1999).
Structural and energetic determinants of the S1-site specificity in serine proteases.
|
| |
Eur J Biochem,
260,
571-595.
|
 |
|
|
|
|
 |
H.Jhoti,
A.Cleasby,
S.Reid,
P.J.Thomas,
M.Weir,
and
A.Wonacott
(1999).
Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
|
| |
Biochemistry,
38,
7969-7977.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Mende,
O.Petoukhova,
V.Koulitchkova,
G.A.Schaub,
U.Lange,
R.Kaufmann,
and
G.Nowak
(1999).
Dipetalogastin, a potent thrombin inhibitor from the blood-sucking insect. Dipetalogaster maximus cDNA cloning, expression and characterization.
|
| |
Eur J Biochem,
266,
583-590.
|
 |
|
|
|
|
 |
T.Niimi,
H.Yokoyama,
A.Goto,
K.Beck,
and
Y.Kitagawa
(1999).
A Drosophila gene encoding multiple splice variants of Kazal-type serine protease inhibitor-like proteins with potential destinations of mitochondria, cytosol and the secretory pathway.
|
| |
Eur J Biochem,
266,
282-292.
|
 |
|
|
|
|
 |
G.De Simone,
A.Lombardi,
S.Galdiero,
F.Nastri,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1998).
Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
|
| |
Protein Sci,
7,
243-253.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.van de Locht,
W.Bode,
R.Huber,
B.F.Le Bonniec,
S.R.Stone,
C.T.Esmon,
and
M.T.Stubbs
(1997).
The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin.
|
| |
EMBO J,
16,
2977-2984.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Lenarcic,
A.Ritonja,
B.Strukelj,
B.Turk,
and
V.Turk
(1997).
Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
|
| |
J Biol Chem,
272,
13899-13903.
|
 |
|
|
|
|
 |
G.F.Lee,
R.A.Lazarus,
and
R.F.Kelley
(1997).
Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins.
|
| |
Biochemistry,
36,
5607-5611.
|
 |
|
|
|
|
 |
G.T.DeKoster,
and
A.D.Robertson
(1997).
Thermodynamics of unfolding for Kazal-type serine protease inhibitors: entropic stabilization of ovomucoid first domain by glycosylation.
|
| |
Biochemistry,
36,
2323-2331.
|
 |
|
|
|
|
 |
J.Klingler,
and
T.Friedrich
(1997).
Site-specific interaction of thrombin and inhibitors observed by fluorescence correlation spectroscopy.
|
| |
Biophys J,
73,
2195-2200.
|
 |
|
|
|
|
 |
M.T.Stubbs,
R.Morenweiser,
J.Stürzebecher,
M.Bauer,
W.Bode,
R.Huber,
G.P.Piechottka,
G.Matschiner,
C.P.Sommerhoff,
H.Fritz,
and
E.A.Auerswald
(1997).
The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition.
|
| |
J Biol Chem,
272,
19931-19937.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Fuentes-Prior,
C.Noeske-Jungblut,
P.Donner,
W.D.Schleuning,
R.Huber,
and
W.Bode
(1997).
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug.
|
| |
Proc Natl Acad Sci U S A,
94,
11845-11850.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Morenweiser,
E.A.Auerswald,
A.van de Locht,
H.Fritz,
J.Stürzebecher,
and
M.T.Stubbs
(1997).
Structure-based design of a potent chimeric thrombin inhibitor.
|
| |
J Biol Chem,
272,
19938-19942.
|
 |
|
|
|
|
 |
S.Di Marco,
and
J.P.Priestle
(1997).
Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
|
| |
Structure,
5,
1465-1474.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.van de Locht,
M.T.Stubbs,
M.Bauer,
and
W.Bode
(1996).
Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite.
|
| |
J Biol Chem,
271,
3413-3416.
|
 |
|
|
|
|
 |
A.van de Locht,
M.T.Stubbs,
W.Bode,
T.Friedrich,
C.Bollschweiler,
W.Höffken,
and
R.Huber
(1996).
The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
|
| |
EMBO J,
15,
6011-6017.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|